USPTO serial 85195224
Serial No. 85195224
Reviewed by CopyMark Law Group
Reg. 4044164Status 710
- Filing date
- Status date
- Registration date
- Oct 25, 2011
- Examiner
- CHHINA, KARANENDRA S
- Law office
- TMO LAW OFFICE 114
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with Serial No. 85195224?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
GOLDEN BIOTECHNOLOGY CORPORATION
Taipei County, TW
GOLDEN BIOTECHNOLOGY CORPORATION
Taipei County, TW
GOLDEN BIOTECHNOLOGY CORPORATION
Taipei County, TW
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Steven M. Rabin
STEVEN M. RABIN RABIN & BERDO, P.C.1101 14TH ST NW STE 500WASHINGTON, DC 20005-5633UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Adjuvants for medical purposes; Antiallergic medicines; Anti-cancer preparations; Medicinal herbal extracts for medical purposes; Pharmaceutical and medicinal preparations and substances for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical and medicinal preparations for the treatment of brain diseases or disorders and autoimmune diseases or disorders; Dietary and nutritional supplements for medical use; Dietary supplements for treating fatigue or liver support; Animal feed additive for use as a nutritional supplement for medical purposes; Dietary supplements for human consumption or for animals; Nutritional additives for medical purposes for use in foods for human consumption or for animals; Animal feed supplements; Dietary pet supplements in the form of pet treats; Fungi preparations for medical or veterinary use for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical preparations and substances for veterinary purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Chemical preparations for medicinal purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments | SECTION 8 - CANCELLED | Nov 1, 2009 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 6, 2022 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Oct 25, 2020 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Mar 15, 2017 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Mar 15, 2017 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Mar 15, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 12, 2017 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Oct 25, 2016 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 25, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 9, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 9, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 7, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 28, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 9, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 9, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 9, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 23, 2011 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 23, 2011 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 23, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 14, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 1, 2011 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Jan 19, 2011 | ALIE | ASSIGNED TO LIE | — |
| Jan 13, 2011 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Dec 15, 2010 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Dec 14, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 14, 2010 | NWAP | NEW APPLICATION ENTERED | — |